Buformin is a biguanide-class oral hypoglycemic agent utilized in the treatment of type 2 diabetes mellitus to improve insulin sensitivity and reduce hepatic glucose production. Laboratories rely on high-quality… Read more
Buformin is a biguanide-class oral hypoglycemic agent utilized in the treatment of type 2 diabetes mellitus to improve insulin sensitivity and reduce hepatic glucose production. Laboratories rely on high-quality reference standards of this compound and its related substances to ensure accurate analytical testing and rigorous quality control. This category includes the active pharmaceutical ingredient, alongside specific impurities and stable isotope labelled compounds such as Buformin-d9 hydrochloride. These materials are critical tools for pharmaceutical researchers and analysts performing impurity profiling, identification of degradation products, and the validation of analytical methods. By providing consistent, reliable standards, these products facilitate precise quantitative analysis and support adherence to regulatory requirements throughout the drug development and manufacturing lifecycle.